Hello, Lykkers! The debate between value and growth investing has occupied financial minds for decades, produced competing camps of devoted practitioners, and generated mountains of academic research—much of it contradictory.

Every investor eventually faces this question: do you buy what is cheap, or do you buy what is growing? The answer, as it turns out, is more nuanced than a simple either-or choice.

Understanding the Two Approaches

Value investing is the older philosophy, articulated most completely by Benjamin Graham. The core idea is straightforward: every asset has intrinsic worth, and markets periodically misprice assets below that worth due to short-term fear or neglect.

Value investors look for stocks trading at low multiples of earnings, book value, or cash flow—essentially buying assets "on sale." As Norm Boersma, Chief Investment Officer of Templeton Global Equity Group, describes it, "It's really about trying to buy something on sale" in the stock market, where the challenge is recognising a bargain without a literal "for sale" sign attached.

Growth investing, by contrast, looks for companies whose future earnings will be substantially larger than their present ones. Growth investors are willing to pay what looks like a premium today in exchange for that future expansion. Classic growth stocks like Amazon in 2010 or Nvidia in 2019 looked expensive on conventional valuation measures at the time—but investors who bought and held were rewarded with returns that value metrics could never have predicted.

What the Data Actually Shows

The honest answer to "which strategy performs better" is that it depends on the time period you examine. Over the past decade, growth has dominated. FE fundinfo data shows the MSCI AC Growth index made a 273.9% total return over the decade to March 2026, compared with 160.9% from its value counterpart.

However, recent years have favoured value more. Over five years, the Growth index still outperforms Value but by a much slimmer margin: 63.2% versus 62.4%. Value has led in most regions, except North America—where US mega-cap tech stocks have skewed indices toward growth. Remove those, and value has quietly reasserted itself across most of the world.

The Expert Perspective

According to GMO's asset allocation team, the long-term case for value is compelling. In its analysis of US stocks, their research shows that 60% of value stocks outperform the market over five-year horizons. They argue that while growth investing can feel more exciting—like chasing the next Nvidia—it comes with a hidden cost: the proportion of growth stocks that go bankrupt is over 50% higher than that of value stocks, and fewer than 40% of growth stocks have outperformed the market over five-year time frames.

Nevertheless, the asset manager notes a crucial caveat: "all investors should be valuation-aware investors, not just dyed-in-the-wool growth or value investors." Starting valuations can sometimes skew the balance toward growth stocks, and in GMO’s analysis of US equities, value stocks are currently trading at a roughly 35% discount to their typical relative valuation.

Why the Binary Is Misleading

Many experts argue that the value-versus-growth framing itself may be outdated. Value and growth are not opposing strategies; they're two dimensions of the same evaluation. A stock can be a value opportunity that is also growing, and vice versa. As veteran investor Howard Marks puts it, "It's not what you buy, it's what you pay for it. There's no reason why a fast-growing company can't be good value or why a low multiple company can't be a good investment."

Marks also observes that traditional value metrics like price-to-book are less relevant in today's economy. "They have few assets and as a result they have this high ratio of price-to-assets but it's meaningless because their potential profitability is not asset-based, it's idea-based, it's code based." This suggests that investors need to be broad-minded, using all tools available rather than rigidly adhering to one style.

What Works Best for You?

The data suggests a few practical takeaways. First, cycles are real: market leadership alternates between growth and value in extended cycles, and timing these shifts is notoriously difficult. Second, both strategies have made investors genuinely wealthy over the long run. Third, the "best" strategy depends on your time horizon, risk tolerance, and temperament—not on which approach is theoretically superior.

Rather than committing entirely to one camp, many advisors now recommend a balanced or hybrid approach that captures value from both disciplines. After all, the most successful investors in history—Warren Buffett included—have blended elements of both styles, buying quality businesses at reasonable prices and holding them for the long term. The debate may continue, but for most investors, the wisest path is not choosing sides—it's borrowing the best from both.

Final Thoughts

The value versus growth debate is unlikely to ever have a definitive winner—and that is perfectly fine. Markets are not static, and neither are the conditions that make one strategy outperform the other. What matters more than picking a side is understanding your own goals, temperament, and time horizon.

For long-term investors, the evidence suggests that a rigid commitment to either style is less important than consistency, patience, and discipline. Both value and growth have produced enormous wealth for those who stayed invested through cycles. The real danger is not choosing the "wrong" strategy—it is abandoning a sound strategy at the worst possible moment simply because the other approach is temporarily in favour.

Perhaps the wisest approach is to borrow from both traditions. Buy quality businesses at reasonable prices. Be willing to pay for growth when the fundamentals justify it. Stay valuation-aware without becoming dogmatic. And remember that in investing, as in life, balance often beats extremism. The goal is not to win the debate—it is to build lasting wealth over decades, not days.